Stockreport

Adverum Biotechnologies to Host a Conference Call and Webcast to Present New Data from the OPTIC Phase 1 Trial with ADVM-022 Intravitreal Gene Therapy in Wet AMD

Adverum Biotechnologies, Inc.  (ADVM) 
Last adverum biotechnologies, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: adverum.gcs-web.com/investor-overview
PDF -- Company to host conference call and webcast with key opinion leaders onMonday, May 4, 2020 at 2:15 pm PT -- REDWOOD CITY, Calif., April 27, 2020 (GLOBE NEWSWIRE) - [Read more]